CD226 Antikörper
-
- Target Alle CD226 Antikörper anzeigen
- CD226
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD226 Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), Immunoprecipitation (IP)
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Immunogen
- Human cytotoxic T lymphocyte clone
- Klon
- DX11
- Isotyp
- IgG1
- Top Product
- Discover our top product CD226 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
- Konservierungsmittel
- Without preservative
-
-
CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells." in: The Journal of biological chemistry, Vol. 278, Issue 38, pp. 36748-53, (2003) (PubMed).
: "
-
CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells." in: The Journal of biological chemistry, Vol. 278, Issue 38, pp. 36748-53, (2003) (PubMed).
-
- Target
- CD226
- Andere Bezeichnung
- CD226 (CD226 Produkte)
- Synonyme
- CD226 antikoerper, cd226 antikoerper, zgc:158817 antikoerper, BC051526 antikoerper, DNAM-1 antikoerper, DNAM1 antikoerper, Pta1 antikoerper, TLiSA1 antikoerper, PTA1 antikoerper, CD226 molecule antikoerper, CD226 antigen antikoerper, CD226 antikoerper, cd226 antikoerper, Cd226 antikoerper
- Hintergrund
- Synonyms: DNAM-1
- Gen-ID
- 10666
- UniProt
- Q15762
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-